Yahoo Finance

MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001

SHANGHAI, China, Feb. 25, 2026 (GLOBE NEWSWIRE) -- MindRank, a clinical-stage artificial intelligence (AI)-empowered drug discovery company, today announced that the first patient has been dosed in ...

Mabylon Reports Positive Phase Ia Results in MY006 Peanut Allergy Trial and Initiates Phase Ib Patient Part of the Study; Advances Tree Pollen Allergy Program MY010 toward ...

Safety Monitoring Committee (SMC) recommended initiation of Part B of the peanut allergy trial Funding secured for follow-on tree (Fagales) ...

Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026 American Society of …

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide ...

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026

MDS-UPDRS scores remained stable and durable across overall study population after 150 days of treatment with ...
JD Supra

Three Key Tips for Drafting Strong Discovery Requests

The discovery phase of a case is critically important. Navigating a case appropriately through the discovery stage can lead to achieving favorable settlement terms, disposing of the case by summary ...
DutchNews.nl

InteRNA Technologies Announces U.S. FDA Clearance of IND Application for Phase I Clinical Trial with Lead microRNA Candidate INT-1B3 in Patients with Advanced Solid Tumors

IND approval enables clinical trial advancement and enrollment of dose expansion cohorts in the US — UTRECHT, The Netherlands–(BUSINESS WIRE)–InteRNA Technologies, a clinical-stage biotech company ...